HR+/HER2- 晚期乳腺癌患者经多线治疗后，往往会出现对多种药物耐药的情况。近年来，抗体偶联药物（ADC）在内分泌治疗失败的 HR+/HER2- 晚期乳腺癌治疗领域取得突破性进展，为这部分患者带来生存希望。为规范临床诊疗行为，使 ADC ...

五年研究结果显示，在Archway研究中接受过平均五次标准治疗玻璃体内注射，并在视力达到或接近峰值时进入研究的患者群体，Susvimo可持续实现疾病控制及视网膜干燥状态。在Susvimo队列中，最佳矫正视力（BCVA）从基线的74.4个字母下降至五年 ...

To improve survival rates after release, the station has allocated 400 mu (about 26.67 hectares) of alpine grassland as a training base, enabling the animals to relearn hunting, risk avoidance, and to ...

"The Western Cape Department of Agriculture wishes to alert poultry farmers and the general public to new outbreaks of high pathogenicity avian influenza, commonly referred to as bird flu," said the ...

本研究报告了一例接受免疫检查点抑制剂（ICIs）治疗的转移性黑色素瘤患者，首次发现IgG4相关性疾病（IgG4-RD）伴间质性肾炎的罕见免疫相关不良反应（irAE）。通过影像学、组织活检及血清学检测证实了IgG4-RD的诊断，糖皮质激素治疗后病灶显著消退。该研究为ICIs治疗中罕见irAE的识别与管理提供了重要临床依据，发表于《BMC Rheumatology》。

of TRACKER FUND (02800) were registered at 9:44a.m. The deals amounted to HK$81.69m, or at HK$25.3 per share, 0.2% higher than previous close. Meanwhile, another direct auto-match trade of 1.14 millio ...